Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Controlled Release Drug Delivery Market size was valued at USD 59.83 billion in 2024 and is likely to cross USD 192.37 billion by 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of controlled release drug delivery is estimated at USD 64.61 billion.
The key factors driving the growth of this market include the low treatment cost, reduced drug toxicity along with the increased therapeutic efficacy. Moreover, these technologies provide various advantages over traditional delivery systems, such as, uniform drug level which stabilizes the medical condition, reduced dosage and less side effects, and is also a significant factor anticipated to fuel the growth of the controlled release drug delivery system market over the forecast period.
Controlled Release Drug Delivery Sector: Growth Drivers and Challenges
Growth Drivers
- Rise in the Population Globally: There is a significant rise in the population of old people and children. Most of the old population suffers from health related problems, such as, compromised physical and mental functions that affect the intake of their medications. In addition, the body of the children and old people cannot tolerate the side effects of the drugs and its high dosage. Hence, with rising population of patients and its various innovations, the controlled release drug delivery market will witness a steep growth during the forecast period
- Advancements in the Drug Delivery Systems: The factor driving the controlled release drug delivery market is the rise in the spending of research & development to cure the non communicable diseases and diseases persisting for a long time, efficiently. The systems are working to be mechanically strong in order to stabilize the medical condition of the patient along with the achievement of high drug loading. Moreover, the research and development is working on cost effective controlled release drug delivery technology, which is estimated to increase the notable rate of its adoption over the forecast period.
Challenges
- High Cost of Controlled Release Drug Delivery Technology and Non-Biocompatibility of Materials Used: Despite of the advantages related to the controlled release drug delivery technology, high cost of the system and non biocompatibility & biodegradability with appropriate controlled release properties of the material used in drugs is expected to act as a key restraint to the growth of controlled release drug delivery market. Further, the inactive substances that act as a medium for a drug are deemed acceptable for the therapy of children are very few and the need for high dose of API (Active Pharmaceutical Ingredient) is hampering the growth of the controlled release drug delivery market.
Controlled Release Drug Delivery Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.4% |
|
Base Year Market Size (2024) |
USD 59.83 billion |
|
Forecast Year Market Size (2037) |
USD 192.37 billion |
|
Regional Scope |
|
Controlled Release Drug Delivery Segmentation
The technology type in controlled release drug delivery market is segmented into wurster technique, implants, targeted delivery, micro encapsulation and others. Based on these segments, the targeted delivery segment will account for the leading share in the market on the back of its improved absorption, low risk of side effects, increased safety and it offers preferred site of action. Moreover, large number of key players has a strong portfolio for the technology. These factors, in turn, are expected to augment the market growth over the forecast period.
Our in-depth analysis of the global controlled release drug delivery market includes the following segments
|
By Product Type |
|
|
By Technology Type |
|
|
By Application Type
|
|
|
By Release Mechanism
|
|
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportControlled Release Drug Delivery Industry - Regional Synopsis
North America industry is expected to account for largest revenue share by 2037, driven by prevailing diseases related to gastrointestinal disorders, advancement in the technological infrastructure of pharmaceutical industry, along with increasing activities of research & development. The increase in the number of gastrointestinal patients will result in the rise in demand for controlled release drug delivery technology. The Asia Pacific market is predicted to be rapidly growing on the back of increase in geriatric and paediatric population in the region, rising demand for the controlled release drugs dosage over the forecast period.
Companies Dominating the Controlled Release Drug Delivery Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mayne Pharma
- AstraZeneca Plc
- Insulet Corporation
- Becton Dickinson and Co
- Bespak
- West Pharmaceutical Services
- Enable Injections Inc
- Biogen Inc.
In the News
On April 22, 2o2o: Researchers at the University of Pittsburgh School Of Medicine developed a new needle delivery system in which the vaccine will penetrate into the upper level of the skin and then release molecules to attack the virus. Additionally, this vaccine improves the immune responses in patients.
Author Credits: Radhika Pawar
- Report ID: 726
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT
